<DOC>
	<DOCNO>NCT00768599</DOCNO>
	<brief_summary>This 6-week clinical study ( 4 week treatment , per day , plus 2-week follow-up period ) topical foam treat athlete 's foot . The active ingredient foam -- econazole nitrate 1 % -- active pharmaceutical ingredient cream doctor currently prescribe treat athlete 's foot . This study help understand foam work cream treat athlete 's foot .</brief_summary>
	<brief_title>A Study Econazole Foam 1 % Athlete 's Foot</brief_title>
	<detailed_description>Treating athlete 's foot cream leave greasy , wet feel foot uncomfortable user messy clothing foot wear . A foam formulation spread easily rubs-in easily effective ( reference ) cream formulation treat athlete 's foot would benefit user . This study design substantiate clinical bridge econazole nitrate foam 1 % econazole nitrate cream 1 % base clinical outcome , safety , pharmacokinetic data . The study ( foam ) vehicle-controlled randomized 1 1 1 ( foam : cream : vehicle ) .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Econazole</mesh_term>
	<criteria>Be least 18 year age either sex . Has clinical diagnosis tinea pedis least ) moderate scaling ( interdigital and/or moccasin ) ii ) mild erythema ( interdigital ) . Be willing give inform consent . Be willing able give inform consent . Has microscopic evidence ( positive KOH ) presence fungi . Evaluable subject must positive KOH fungal culture positive dermatophyte Baseline . Subjects positive KOH may enter study pending result fungal culture . Be good health free disease physical condition might , investigator 's opinion , expose subject unacceptable risk study participation . Women childbearing potential must negative urine pregnancy test agree use effective , nonprohibited form birth control duration study ( abstinence , stabilize oral contraceptive least two month , implant , injection , IUD , patch , NuvaRing , condom spermicidal diaphragm spermicidal ) . Is nurse plan pregnancy study . Has use topical antifungal corticosteroid therapy systemic antibacterial therapy within 30 day prior start study . Has receive systemic antifungal therapy within 12 week prior start study medication . Has history diabetes mellitus immunocompromised ( due disease , e.g. , HIV , medication ) . Has concurrent tinea infection ( opinion investigator ) . However , concurrent onychomycosis allow . Has skin disease might interfere evaluation tinea pedis . Is currently enrol investigational drug device study . Has receive investigational drug treatment investigational device within 30 day prior enter study Is unreliable , include subject history drug alcohol abuse . Has know hypersensitivity component study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Econazole</keyword>
	<keyword>Foam</keyword>
	<keyword>Quinnova</keyword>
</DOC>